Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165040PMC
http://dx.doi.org/10.1016/j.mycmed.2021.101161DOI Listing

Publication Analysis

Top Keywords

mucormycosis killer
4
killer shadow
4
shadow covid-19
4
mucormycosis
1
shadow
1
covid-19
1

Similar Publications

Article Synopsis
  • - COVID-19, caused by the virus SARS-CoV-2, has become a global pandemic with significant health impacts.
  • - Analysis of past SARS data suggests that fungal co-infections during the COVID-19 pandemic may often go unnoticed or incorrectly diagnosed.
  • - The report includes case studies of patients who developed fungal infections in the maxilla and orbit after recovering from COVID-19, highlighting successful treatment and ongoing monitoring.
View Article and Find Full Text PDF

Germline pathogenic variants (PVs) in the gene encoding the GATA2 transcription factor can result in profound reductions of monocytes, dendritic cells, natural killer cells and B cells. GATA2 PVs are associated with an increased risk of myeloid malignancies and a predisposition to nontuberculous mycobacterial and human papillomavirus infections. Additionally, invasive fungal infections (IFIs) have been reported in individuals with GATA2 PVs, even in the absence of myeloid malignancies.

View Article and Find Full Text PDF

Defective antifungal immunity in patients with COVID-19.

Front Immunol

December 2022

Public Health Wales, Microbiology Cardiff, Wales, United Kingdom.

The COVID-19 pandemic has placed a huge strain on global healthcare and been a significant cause of increased morbidity and mortality, particularly in at-risk populations. This disease attacks the respiratory systems and causes significant immune dysregulation in affected patients creating a perfect opportunity for the development of invasive fungal disease (IFD). COVID-19 infection can instill a significant, poorly regulated pro-inflammatory response.

View Article and Find Full Text PDF

Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review.

Orbit

December 2022

Ophthalmic Plastic Surgery Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.

Article Synopsis
  • The literature review focuses on the immunopathological changes caused by COVID-19 and their possible link to the development of rhino-orbital-cerebral mucormycosis (ROCM).
  • COVID-19 disrupts respiratory epithelial integrity, compromises immune function, and creates a favorable environment for Mucorales fungal invasion due to various factors, including hyperglycemia and immune cell dysfunction.
  • The findings suggest that COVID-19 facilitates ROCM development through mechanisms affecting the respiratory mucosa and impairing both innate and adaptive immunity, alongside promoting conditions like iron overload.
View Article and Find Full Text PDF

Mucormycosis is a group of infections, caused by multiple fungal species, which affect many human organs and is lethal in immunocompromised patients. During the COVID-19 pandemic, the current wave of mucormycosis is a challenge to medical professionals as its effects are multiplied because of the severity of COVID-19 infection. The variant of concern, Omicron, has been linked to fatal mucormycosis infections in the US and Asia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!